CALIDI BIOTHERAPEUTICS INC
Public company snapshot, recent ticker-linked headlines, and a path into evidence-backed AI research.
Latest price
$0.69
+2.43%
Alpha Vantage · 10/30/2026
One-year price history
Adjusted daily closes · 252 observations · as of Oct 30, 2026
1 month
-36.3%
3 months
-59.0%
6 months
-80.1%
1 year
-97.3%
Year to date
-96.3%
52-week range
$0.64 – $26.56
Fundamental snapshot
Latest reported period: Jun 30, 2026
Market cap
$1.8M
P/E
-0.1
P/B
0.6
P/S
—
Revenue
$0
Net income
-$17.47M
Diluted EPS
-38.24
Gross margin
—
Net margin
—
Return on equity
-500.50%
Total debt
$1.94M
Cash
$4.07M
Free cash flow
-$17.85M
Latest eight reported quarters
Reported quarterly values, newest first
| Period | Revenue | Net income | Gross margin | Net margin | Free cash flow |
|---|---|---|---|---|---|
| Jun 30, 2026 | $0 | -$4.16M | — | — | -$4.39M |
| Mar 31, 2026 | $0 | -$4.11M | — | — | -$4.12M |
| Dec 31, 2025 | $0 | -$4.06M | — | — | -$5.07M |
| Sep 30, 2025 | $0 | -$5.15M | — | — | -$4.27M |
| Jun 30, 2025 | $0 | -$5.72M | — | — | -$4.94M |
| Jun 30, 2025 | $0 | -$5.72M | — | — | -$4.94M |
| Mar 31, 2025 | $0 | -$4.99M | — | — | -$7.14M |
| Mar 31, 2025 | $0 | -$4.99M | — | — | -$7.14M |
Reported figures can reflect company reporting conventions, restatements, or sector-specific accounting. Verify against filings before relying on a valuation comparison.
Recent CLDI news
All market newsNo ticker-linked stories are in the current archive.